DNAprint Genomics (DNAG)

[dgplexus]

bag8ger,

I think averaging down is an important practice, with any promising R&D stock, whether it's in pennyland or on the big board.

I think it's wise to avoid using all your powder at once (hold back for those averaging-down opportunities,) and keep an eye on value. If the company's value (factoring in potential and likely outcomes,) is no longer greater than its market cap, then of course, it no longer makes sense to average down, with that stock. I think DNAG is definitely worth _much_ more than its market cap.